Dr. Kimberly Ritrievi

Dr. Kimberly Ritrievi, Director, Audit Committee Chair - Current President, The Ritrievi Group, LLC

Dr. Kimberly Ritrievi currently serves on Mativ’s Board of Directors as its Audit Committee Chair and has served on the former SWM International Board of Directors since 2018. She is currently President at The Ritrievi Group, LLC, a consultancy focused on equity value-creation for public and private technology and chemical companies from 2005 to 2018 and on private investing from 2018 to the present.

Prior to founding The Ritrievi Group, LLC, she served in numerous leadership positions at Goldman Sachs & Co., including as Co-Director of Investment Research for the U.S., Canada, Latin and South America from 2001 to 2004. Previously, Kimberly was a Specialty Chemicals Analyst at Goldman Sachs & Co., Credit Suisse First Boston, Lehman Brothers and UBS Wealth Management (fka Paine Webber). She started her career as a process development engineer at ARCO Chemical. 

She also serves as a Director, Audit Committee Financial Expert and Chair of the Strategic Planning & Enterprise Risk Committee of Tetra Tech, a Board she joined in 2013.

Kimberly received her ScD in Chemical Engineering from the Massachusetts Institute of Technology (MIT), holds an MS in Management from the MIT Sloan School of Management and earned a BSE from Princeton University. She also continues to serve on advisory boards at Princeton University, MIT and the Wellesley Centers for Women.